Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Type 2 diabetes mellitus is a progressive disease associated with significant morbidity and mortality. There is good evidence showing that intensive glycemic control reduces the development and progression of complications. In order to achieve glycemic targets, patients often require a combination o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Jennifer, Anderson, Rosie, Stephens, Jeffrey W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958358/
https://www.ncbi.nlm.nih.gov/pubmed/27486305
http://dx.doi.org/10.2147/DDDT.S93076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958358/
https://www.ncbi.nlm.nih.gov/pubmed/27486305
http://dx.doi.org/10.2147/DDDT.S93076

Ejemplares similares